Guangdong GD Kongming Biotech LLC.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2018-03-12
- Employees
- -
- Market Cap
- -
- Website
- https://www.gdkongming.com
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
Phase 1
Withdrawn
- Conditions
- Advanced Hepatocellular Carcinoma
- Interventions
- Biological: GDKM-100 injection
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Guangdong GD Kongming Biotech LLC
- Registration Number
- NCT05628545
- Locations
- 🇨🇳
Zhuhai People'S Hospital, Zhuhai, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath